Variant report
Variant | esv3388206 |
---|---|
Chromosome Location | chr7:136851412-136852460 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr7:136851161-136851454 | IMR90 | lung: | n/a | chr7:136851307-136851316 |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000234352 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535533645 | chr7:136851415-136851416 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs555876511 | chr7:136851474-136851475 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs832958 | chr7:136851486-136851487 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs547970749 | chr7:136851581-136851582 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544556061 | chr7:136851626-136851627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557872833 | chr7:136851627-136851628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs367695011 | chr7:136851628-136851629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs371254146 | chr7:136851706-136851707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568084333 | chr7:136851756-136851757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533533755 | chr7:136851768-136851769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547296463 | chr7:136851770-136851771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs566792769 | chr7:136851775-136851776 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560655795 | chr7:136851776-136851777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538854520 | chr7:136851902-136851903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs71176385 | chr7:136851920-136851921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs67986741 | chr7:136851921-136851922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529555923 | chr7:136852131-136852132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs833013 | chr7:136852147-136852148 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs138557158 | chr7:136852167-136852168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531307622 | chr7:136852240-136852241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs34590530 | chr7:136852313-136852314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs140117310 | chr7:136852420-136852421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs117000853 | chr7:136852437-136852438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs547316111 | chr7:136852456-136852457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs567120726 | chr7:136852457-136852458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Melanoma | 19188590 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Coffin-Siris syndrome | 21572526 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Low-grade fibromyxoid sarcoma | 21536545 | CNVD |
Breast cancer | 16272173 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Stuttering | 21108403 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Neuroticism | 17667963 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:136850400-136854000 | Weak transcription | Fetal Kidney | kidney |
2 | chr7:136850600-136851600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr7:136850800-136851600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr7:136851200-136853800 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr7:136851200-136853800 | Weak transcription | Fetal Stomach | stomach |